文献速递生殖医学

黄体期孕酮补充是否影响改良自然周期冻融胚胎移植女性的身体与心理社会健康?一项随机对照试验的子研究

Does luteal phase progesterone supplementation affect physical and psychosocial well-being among women undergoing modified natural cycle-FET? A sub-study of a randomized controlled trial.
PubMed 文献 · Hum Reprod · 2023-01-01

该研究为一项在丹麦八家生育诊所开展的随机对照试验的子研究,纳入286名接受改良自然周期冻融胚胎移植的女性,比较阴道孕酮黄体期支持与不用药对身体及心理社会健康的影响。结果显示孕酮组阴道瘙痒和/或灼烧感更多(P < 0.001),心理社会健康两组无差异;自我报告的阴道酵母菌感染在多重检验校正后不显著(P/adjusted P = 0.049/0.881)。

要点

  • 孕酮组阴道瘙痒和/或灼烧感较非孕酮组更常见(P < 0.001)。
  • 两组心理社会健康无差异。
  • 孕酮组自我报告阴道酵母菌感染在校正后不显著(P/adjusted P = 0.049/0.881)。

核心结论

  • 接受改良自然周期冻融胚胎移植并使用阴道孕酮的女性更可能经历身体不适,但两组心理社会健康无差异。

研究设计与样本

  • 一项正在进行的随机对照试验的子研究,该随机对照试验在丹麦八家生育诊所于2019年开始,计划于2024年初结束。
  • 子研究基于2019年8月加入随机对照试验的两份关于身体和心理社会健康的问卷。
  • 数据提取时共有286名女性回答了两份问卷,每组143人。

主要发现

  • 孕酮组女性经历阴道瘙痒和/或灼烧感多于非孕酮组(P < 0.001)。
  • 孕酮组自我报告阴道酵母菌感染更多,但多重检验校正后不显著(P/adjusted P = 0.049/0.881)。
  • 两组心理社会健康无差异。
  • 孕酮组内,比较基线与囊胚移植后的应答分布,发现倾向于感觉较少「沮丧和忧郁」(P < 0.001)。

临床怎么用

  • 作者认为,给药前应考虑孕酮的身体副作用。

局限性

  • 所有身体症状条目均为自我报告,阴道酵母菌感染条目未经医生诊断。
  • 研究纳入需要额外到诊所访视几次,对生育治疗感到负担更重的参与者可能更可能拒绝参与。
  • 在此冻融胚胎移植周期前对孕酮经历很多副作用的女性可能更不可能参与。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are there any differences in physical and psychosocial well-being among women undergoing modified natural cycle frozen embryo transfer (mNC-FET) with or without vaginal progesterone as luteal phase support (LPS)? SUMMARY ANSWER: Women undergoing mNC-FET with vaginal progesterone supplementation were more likely to experience physical discomfort but there was no difference in psychosocial well-being between the two groups. WHAT IS KNOWN ALREADY: mNC-FET can be carried out with or without vaginal progesterone as LPS, which has several side-effects. It is commonly known that fertility treatment can cause stress and psychosocial strain, however, most studies on this subject are conducted in fresh cycle regimes, which differ from NC-FET and results may not be comparable. STUDY DESIGN, SIZE, DURATION: This is a sub-study of an ongoing RCT investigating whether progesterone supplementation has a positive effect on live birth rate in mNC-FET. The RCT is conducted at eight fertility clinics in Denmark from 2019 and is planned to end primo 2024. The sub-study is based on two questionnaires on physical and psychosocial well-being added to the RCT in August 2019. On the time of data extraction 286 women had answered both questionnaires. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women who had answered both questionnaires were included in the sub-study. Participants were equally distributed, with 143 in each of the two groups. Participants in both groups received the same questionnaires at two time-points: on cycle day 2-5 (baseline) and after blastocyst transfer. Participants in the progesterone group had administered progesterone for 7 days upon answering the second questionnaire. All items in the questionnaires were validated. Items on psychosocial well-being originate from the Copenhagen Multi-Centre Psychosocial Infertility-Fertility Problem Stress Scale (COMPI-FPSS) and from the Mental Health Inventory-5. MAIN RESULTS AND THE ROLE OF CHANCE: Women receiving progesterone experienced more vaginal itching and/or burning than women in the non-progesterone group (P < 0.001). Women in the progesterone group also experienced more self-reported vaginal yeast infection, this was, however, not significant after adjustment for multiple testing (P/adjusted P = 0.049/0.881). No differences regarding psychosocial well-being were found between the two groups. Within the progesterone group, a shift toward feeling less 'downhearted and blue' was found when comparing response distribution at baseline and after blastocyst transfer (P < 0.001). LIMITATIONS, REASONS FOR CAUTION: All items on physical symptoms were self-reported. The item on vaginal yeast infection was therefore not diagnosed by a doctor. Inclusion in the study required a few extra visits to the clinic, participants who felt more burdened by fertility treatment might have been more likely to decline participation. Women who experienced a lot of side-effects to progesterone prior to this FET cycle, might be less likely to participate. WIDER IMPLICATIONS OF THE FINDINGS: Our results are in line with previous known side-effects to progesterone. Physical side-effects of progesterone should be considered before administration. STUDY FUNDING/COMPETING INTEREST(S): The RCT is fully supported by Rigshospitalet's Research Foundation and a grant from Gedeon Richter. Gedeon Richter were not involved in the design of protocol nor in the conduction of the study or analysis of results. A.P., L.P., and N.I.-C.F. report grants from Gedeon Richter, Ferring and Merck with no relations to this study. N.I.-C.F. has received travel support from Ferring, Merck A/S, & Gideon Richter, and is the head of the steering committee for the Danish Fertility Guidelines made by the members of from the Danish Fertility Society. A.P. reports consulting fees from Preglem, Novo Nordisk, Ferring, Gedeon Richter, Cryos, & Merck A/S, honoraria from Gedeon Richter, Ferring, Merck A/S, Theramex, and Organon, has received travel support from Gedeon Richter (payment to institution), participated on an advisory board for Preglem and was loaned an embryoscope from Gedeon Richter to their institution. A.L.S. has stock options for Novo Nordisk B A/S. B.A. have received unrestricted grant from Gedeon Richter Nordic and Merck and honoraria for lectures from Gedeon Richter, Merck, IBSA, and Marckyrl Pharma. TRIAL REGISTRATION NUMBER: The RCT is registered on ClinicalTrials. gov (NCT03795220) and in EudraCT (2018-002207-34).

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Colombo C, Pistoljevic-Kristiansen N, Saupstad M, et al. Does luteal phase progesterone supplementation affect physical and psychosocial well-being among women undergoing modified natural cycle-FET? A sub-study of a randomized controlled trial. Hum Reprod. 2023. PMID: 37634089. doi:10.1093/humrep/dead171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。